Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Curr Colorectal Cancer Rep. 2013 Jun 1;9(2):198–202. doi: 10.1007/s11888-013-0164-7

Figure 1. Optimal morphologic response after systemic chemotherapy.

Figure 1

Group 3 morphology with heterogeneous attenuation and ill defined margin was converted to group 1 morphology with homogeneous attenuation and sharp margin after systemic chemotherapy with bevacizumab.